NEW YORK (GenomeWeb News) – The US Senate yesterday confirmed Margaret Hamburg, a biothreat expert with experience running a large organization in New York, and with studying pathogens at the National Institutes of Health, to take over as commissioner at the Food and Drug Administration.

Department of Health and Human Services Director Kathleen Sebelius in a statement called Hamburg "an inspiring public health leader with broad experience in infectious disease, bioterrorism, and health policy. "Her expertise and judgment will serve FDA well," Sebelius said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.